Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tariq Afroz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Chimia|May 24, 2019
Structural Transition, Function and Dysfunction of TDP-43 in Neurodegenerative DiseasesTariq Afroz, Manuela Pérez-Berlanga, Magdalini Polymenidou
Methods in Enzymology|June 13, 2015
One, Two, Three, Four! How Multiple RRMs Read the Genome SequenceTariq Afroz, Zuzana Cienikova, Antoine Cléry, et al.
IUBMB Life|January 26, 2016
Insight into the role of histidine in RNR motif of protein component of RNase P of M. tuberculosis in catalysisAlla Singh, Anup K Ramteke, Tariq Afroz, et al.
Genes & Development|July 4, 2014
A fly trap mechanism provides sequence-specific RNA recognition by CPEB proteinsTariq Afroz, Lenka Skrisovska, Eulàlia Belloc, et al.
Scientific Reports|October 27, 2017
Split GFP technologies to structurally characterize and quantify functional biomolecular interactions of FTD-related proteinsChiara Foglieni, Stéphanie Papin, Agnese Salvadè, et al.
Molecular Neurobiology|August 22, 2018
Memory Decline and Its Reversal in Aging and Neurodegeneration Involve miR-183/96/182 BiogenesisAli Jawaid, Bisrat T Woldemichael, Eloïse A Kremer, et al.
Acta Neuropathologica Communications|October 4, 2024
Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTDElodie Chevalier, Mickael Audrain, Monisha Ratnam, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2025
A single dose of a vectorized mAb targeting TDP-43 potently inhibits the neuropathology in a model of ALS/FTDGreg Del Val, Florence Gauye, Mickaël Audrain, et al.
Nature Communications|July 1, 2017
Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregationTariq Afroz, Eva-Maria Hock, Patrick Ernst, et al.
Mabs|July 6, 2023
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human frameworkRomain Ollier, Aline Fuchs, Florence Gauye, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Chimia|May 24, 2019
Structural Transition, Function and Dysfunction of TDP-43 in Neurodegenerative DiseasesTariq Afroz, Manuela Pérez-Berlanga, Magdalini Polymenidou
Methods in Enzymology|June 13, 2015
One, Two, Three, Four! How Multiple RRMs Read the Genome SequenceTariq Afroz, Zuzana Cienikova, Antoine Cléry, et al.
IUBMB Life|January 26, 2016
Insight into the role of histidine in RNR motif of protein component of RNase P of M. tuberculosis in catalysisAlla Singh, Anup K Ramteke, Tariq Afroz, et al.
Genes & Development|July 4, 2014
A fly trap mechanism provides sequence-specific RNA recognition by CPEB proteinsTariq Afroz, Lenka Skrisovska, Eulàlia Belloc, et al.
Scientific Reports|October 27, 2017
Split GFP technologies to structurally characterize and quantify functional biomolecular interactions of FTD-related proteinsChiara Foglieni, Stéphanie Papin, Agnese Salvadè, et al.
Molecular Neurobiology|August 22, 2018
Memory Decline and Its Reversal in Aging and Neurodegeneration Involve miR-183/96/182 BiogenesisAli Jawaid, Bisrat T Woldemichael, Eloïse A Kremer, et al.
Acta Neuropathologica Communications|October 4, 2024
Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTDElodie Chevalier, Mickael Audrain, Monisha Ratnam, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2025
A single dose of a vectorized mAb targeting TDP-43 potently inhibits the neuropathology in a model of ALS/FTDGreg Del Val, Florence Gauye, Mickaël Audrain, et al.
Nature Communications|July 1, 2017
Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregationTariq Afroz, Eva-Maria Hock, Patrick Ernst, et al.
Mabs|July 6, 2023
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human frameworkRomain Ollier, Aline Fuchs, Florence Gauye, et al.
Pageof 2